Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Cara Therapeutics- Inc. (CARA)

12.43 0 (+0.00%)

10/23/2017  4:00pm

Open:

12.45

Pre. Close:

12.43

High:

12.70

Low:

12.22

Volume:

564,425

Market Cap:

404.98M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

12.89 - 13.08

13.08 - 13.22

Low:

11.67 - 11.85

11.85 - 11.98

Close:

12.1 - 12.49

12.49 - 12.77

Technical analysis  (as of: 2017-10-23 4:37:29 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 15.68     One year: 16.64

Support:

Support1: 12.08    Support2: 10.05

Resistance:

Resistance1: 13.42    Resistance2: 14.25

Pivot:

13.08

Moving Averages:

MA(5): 12.42     MA(20): 13.18

MA(100): 14.96     MA(250): 14.16

MACD:

MACD(12,26): -0.32     Signal(12,26,9): -0.23

%K %D:

%K(14,3): 15.21     %D(3): 12.90

RSI:

RSI(14): 37.91

52-Week:

High: 28.50  Low: 5.85  Change(%): 65.5

Average Vol(K):

3-Month: 91094  10-Days 71430

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CARA has closed above bottom band by 22.8%. Bollinger Bands are 52.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to CARA's normal range. The bands have been in this narrow range for 40 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 19 Oct 2017 11:37:30 GMT
3 Reasons Cara Therapeutics Is a Better Growth Stock Than Novavax

Mon, 16 Oct 2017 10:52:30 GMT
Cara Therapeutics Announces Successful End-of-Phase 2 Meeting with FDA for IV ...

Mon, 23 Oct 2017 14:26:15 GMT
Hot On The Charts: Comcast Corporation (CMCSA), Cara Therapeutics, Inc. (CARA)

Thu, 12 Oct 2017 16:08:15 GMT
Commit To Purchase Cara Therapeutics At $10, Earn 25.1% Annualized Using Options

Fri, 06 Oct 2017 09:56:15 GMT
Where Will Cara Therapeutics Be in 5 Years?

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

Shares Float (M)

27.43

% Held by Insiders

8.97

% Held by Institutions

65.52

Shares Short (K)

595

Shares Short Prior Month (K)

570

Stock Financials

EPS

-2.280

EPS Est. Current Year

-1.780

EPS Est. Next Year

-1.860

EPS Est. Next Quarter

-0.380

Forward EPS

-1.860

Book Value (p.s.)

3.350

PEG Ratio

Profit Margin

Operating Margin

-7249.95

Return on Assets (ttm)

-39.3

Return on Equity (ttm)

-67.8

Qtrly Rev. Growth

Gross Profit (p.s.)

0.003

Sales Per Share

EBITDA (p.s.)

-1.986

Qtrly Earnings Growth

Operating Cash Flow (M)

-59.65

Levered Free Cash Flow (M)

-36.44

FoxReading.com

Valuation

P/E

-5.45

P/E Growth Ratio

P/BV

3.71

P/S

13498980352.00

P/CF

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.